Hutchison China MediTech Limited announces Dr. Karen Jean Ferrante has been appointed as Independent Non-Executive Director, Chairman of Technical Committee and member of Audit Committee and Professor Christopher Huang tendered his resignation as Independent Non-Executive Director, Chairman of Technical Committee and member of Audit Committee. Dr. Ferrante is currently a member of the board of directors of Progenics Pharmaceuticals Inc., and MacroGenics Inc. She was previously a director of Baxalta Incorporated until it was acquired by Shire Pharmaceuticals in 2016.